JP2025502943A5 - - Google Patents
Info
- Publication number
- JP2025502943A5 JP2025502943A5 JP2024539810A JP2024539810A JP2025502943A5 JP 2025502943 A5 JP2025502943 A5 JP 2025502943A5 JP 2024539810 A JP2024539810 A JP 2024539810A JP 2024539810 A JP2024539810 A JP 2024539810A JP 2025502943 A5 JP2025502943 A5 JP 2025502943A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- heterocycloalkyl
- haloalkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2022/074739 | 2022-01-28 | ||
| CN2022074739 | 2022-01-28 | ||
| CNPCT/CN2022/140318 | 2022-12-20 | ||
| CN2022140318 | 2022-12-20 | ||
| PCT/CN2023/073579 WO2023143520A1 (en) | 2022-01-28 | 2023-01-28 | Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502943A JP2025502943A (ja) | 2025-01-30 |
| JP2025502943A5 true JP2025502943A5 (https=) | 2026-02-04 |
Family
ID=87470622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539810A Pending JP2025502943A (ja) | 2022-01-28 | 2023-01-28 | エクトヌクレオチドピロホスファターゼ－ホスホジエステラーゼ１（ｅｎｐｐ１）阻害剤およびその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250101019A1 (https=) |
| EP (1) | EP4469456A4 (https=) |
| JP (1) | JP2025502943A (https=) |
| KR (1) | KR20240142481A (https=) |
| CN (1) | CN118871439A (https=) |
| AR (1) | AR128383A1 (https=) |
| AU (1) | AU2023213905A1 (https=) |
| CA (1) | CA3247162A1 (https=) |
| IL (1) | IL313821A (https=) |
| MX (1) | MX2024009216A (https=) |
| TW (1) | TW202340190A (https=) |
| WO (1) | WO2023143520A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024074128A1 (en) * | 2022-10-08 | 2024-04-11 | Insilico Medicine Ip Limited | Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof |
| CN121793967A (zh) * | 2023-07-06 | 2026-04-03 | 英矽智能科技知识产权有限公司 | 外切核苷酸焦磷酸酶/磷酸二酯酶1 (enpp1)抑制剂组合及其用途 |
| CN121969621A (zh) * | 2023-08-02 | 2026-05-01 | 英矽智能科技知识产权有限公司 | 外核苷酸焦磷酸酶-磷酸二酯酶1 (enpp1)抑制剂的结晶形式及其用途 |
| WO2025026377A1 (en) * | 2023-08-02 | 2025-02-06 | Insilico Medicine Ip Limited | Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp1) inhibitors and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT98674B (pt) * | 1990-08-15 | 1999-01-29 | British Bio Technology | Processo para a preparacao de compostos que sao antagonistas do factor de activacao de plaquetas por exemplo derivados de imidazole e de seus intermedriarios |
| GB9200209D0 (en) * | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
| US6489338B2 (en) * | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
| KR101142363B1 (ko) * | 2005-06-27 | 2012-05-21 | 주식회사유한양행 | 피롤로피리딘 유도체를 포함하는 항암제 조성물 |
| PE20081354A1 (es) * | 2006-11-30 | 2008-11-14 | Genentech Inc | Compuestos de azaindolilo como inhibidores de mek |
| WO2015038417A1 (en) * | 2013-09-10 | 2015-03-19 | Asana Biosciences, Llc | Compounds for regulating fak and/or src pathways |
| WO2019023635A1 (en) * | 2017-07-27 | 2019-01-31 | Stingray Therapeutics, Inc. | SUBSTITUTED 3 H-IMIDAZO (4,5-C) PYRIDINE AND 1H-PYRROLO (2,3-C) PYRIDINE SERIES OF A NOVEL ECTONUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE-1 (ENPP1) AND STIMULATOR FOR A GENE MODULATOR INTERFERON (STING) AS IMMUNOTHERAPEUTIC AGENTS AGAINST CANCER |
| CN111732584B (zh) * | 2019-03-25 | 2024-02-27 | 复旦大学 | 二芳基取代稠杂环类化合物及其制备方法和在制药中的用途 |
| ES2960987T3 (es) * | 2019-04-12 | 2024-03-07 | Riboscience Llc | Derivados de heteroarilo bicíclicos como inhibidores de la ectonucleótido pirofosfatasa fosfodiesterasa 1 |
| KR20220068243A (ko) * | 2019-09-23 | 2022-05-25 | 난징 젱시앙 파마슈티칼스 컴퍼니 리미티드 | 포스포디에스테라제 억제제 및 용도 |
| MX2023008761A (es) * | 2021-01-29 | 2023-08-22 | Txinno Bioscience Inc | Derivado de benzotriazol novedoso que posee actividad inhibitoria contra la ectonucleotido pirofosfatasa - fosfodiesterasa y uso del mismo. |
-
2023
- 2023-01-28 IL IL313821A patent/IL313821A/en unknown
- 2023-01-28 JP JP2024539810A patent/JP2025502943A/ja active Pending
- 2023-01-28 US US18/832,564 patent/US20250101019A1/en active Pending
- 2023-01-28 MX MX2024009216A patent/MX2024009216A/es unknown
- 2023-01-28 EP EP23746397.1A patent/EP4469456A4/en active Pending
- 2023-01-28 WO PCT/CN2023/073579 patent/WO2023143520A1/en not_active Ceased
- 2023-01-28 AU AU2023213905A patent/AU2023213905A1/en active Pending
- 2023-01-28 KR KR1020247028329A patent/KR20240142481A/ko active Pending
- 2023-01-28 CN CN202380026751.8A patent/CN118871439A/zh active Pending
- 2023-01-28 CA CA3247162A patent/CA3247162A1/en active Pending
- 2023-01-30 AR ARP230100212A patent/AR128383A1/es unknown
- 2023-01-30 TW TW112102960A patent/TW202340190A/zh unknown